Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04561414
Other study ID # Stryker03
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date May 2021
Est. completion date May 2022

Study information

Verified date April 2021
Source Stryker Orthopaedics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical trial is a prospective, multi-center, single-blind, parallel, randomized controlled superiority clinical trial. The trial will be carried out in 5 centers, involving 120 subjects as estimated who will be divided into the test group or control group randomly on an equal basis (each group includes 60 subjects). This trial will be carried out in 4 stages, including the screening period, random grouping, operation date and follow-up period. In the screening period, the informed consent forms are collected and candidates are screened; after screening, the accepted subjects will be randomly divided into the control group or test group; on the operation date, the operation is carried out using the device tested; safety follow-up visit is carried out during the follow-up period.


Description:

The prospective, multi-center, single-blind, parallel, randomized controlled superiority trial design is adopted to evaluate the safety and effectiveness of the LED light source system for endoscope during ureter transillumination. The trial will be carried out in 5 centers, with the competitive grouping mode adopted. This trial will be carried out in the General Surgery Department and the Gynecology Department. Totally 120 subjects with rectal cancer, endometriosis, cervical cancer, adenomyosis and pelvic adhesion requiring operation (60 subjects for each of the test group and control group) are involved. The subjects, after signing the informed consent form approved by the Ethics Committee, will be screened by the investigators. Qualified subjects who meet all the inclusion criteria and do not meet any of the exclusion criteria will be randomly divided into the control group or the test group. The subjects in the control group will accept the ureteral stent (manufacturer: Cook Ireland Ltd.) during operation. The subjects in the test group will undergo surgery using the LED light source system for endoscope and the supporting IRIS ureter kit. On the operation date, the investigators will score the performance using a scale to evaluate the resolution of the ureter in the whole process of operation. During the follow-up period, the investigators will evaluate the safety of the device based on the results of vital signs, physical examination, blood routine examination, routine urine examination, blood biochemistry, 12-lead ECG and B-mode ultrasonography of urinary system.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 2022
Est. primary completion date May 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility 1. Inclusion Criteria: 1. The surgeon believes preventative placement of a ureteral stent is necessary and the target organ to be excised in the surgery is closely related to the ureter (e.g. representative specialized operations such as rectal cancer and endometriosis, cervical cancer, adenomyosis and pelvic adhesion). 2. Age: 18 to 80 years old; 3. All subjects voluntarily participate in the clinical trial and are asked to sign the informed consent form. 2. Exclusion Criteria: 1. Women during pregnancy or lactation; 2. Subjects are involved in other clinical trials at the same time; Hydronephrosis due to urinary tract obstruction; Laparotomy is expected (except for conversion to laparotomy during operation); 3. Other conditions deemed by the investigators as unsuitable for operation; 4. Other conditions deemed by the investigators as unsuitable for the trial (including anticipated catheterizing failure).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
LED light source system for endoscope
The prospective, multi-center, single-blind, parallel, randomized controlled superiority trial design is adopted to evaluate the safety and effectiveness of the LED light source system for endoscope during ureter transillumination. The trial will be carried out in 5 centers, with the competitive grouping mode adopted. This trial will be carried out in the General Surgery Department and the Gynecology Department. Totally 120 subjects with rectal cancer, endometriosis, cervical cancer, adenomyosis and pelvic adhesion requiring operation (60 subjects for each of the test group and control group) are involved. The test group use LED light source system for endoscope.
Ureteral stent (Cook Ireland Ltd.)
The prospective, multi-center, single-blind, parallel, randomized controlled superiority trial design is adopted to evaluate the safety and effectiveness of the LED light source system for endoscope during ureter transillumination. The trial will be carried out in 5 centers, with the competitive grouping mode adopted. This trial will be carried out in the General Surgery Department and the Gynecology Department. Totally 120 subjects with rectal cancer, endometriosis, cervical cancer, adenomyosis and pelvic adhesion requiring operation (60 subjects for each of the test group and control group) are involved. The test group use Ureteral stent (Cook Ireland Ltd.).

Locations

Country Name City State
China Beijing Chao-Yang Hospital,Capital Medical University Beijing Beijing
China Xuanwu Hospital, Capital Medical University Beijing Beijing
China The First Affiliated Hospital of Jilin University Jilin Changchun
China Obstetrics&Gynecology Hospital of Fudan University Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Stryker Orthopaedics

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Resolution of the ureter in the whole operation. On the operation date, the investigators will score the performance using a scale (1 very good - 10 worst outcome) to evaluate the resolution of the ureter in the whole process of operation. in the whole process of operation
See also
  Status Clinical Trial Phase
Recruiting NCT03328481 - Quadratus Lumborum Block Using Loss-of-resistance Versus Ultrasound-guided Technique N/A
Completed NCT06050044 - Intrathecal Injection of Hyperbaric Bupivacaine Versus a Mixture of Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Lower Abdominal Surgery N/A
Completed NCT02398123 - Transversus Abdominis Plane Versus Caudal Block for Pediatrics Phase 1
Completed NCT03808129 - Erector Spinae Plane Block for Peroperative Analgesia and Intraabdominal Tissue Oxygenation N/A
Recruiting NCT05524038 - Comparison Between the Quadratus Lumborum Block ,Erector Spinae Plane Block in Lower Abdominal Surgery N/A
Completed NCT05284734 - Comparison of Caudal Block and Erector Spinae Block for Postoperative Analgesia N/A